Clinical Trial Update: Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating long-term use of SGLT inhibitors to prevent chronic kidney disease progression in Type 1 diabetes; the study is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 1 Diabetes Mellitus

Drugs mentioned

• SGLT inhibitors

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Nephropathy, Diabetic Nephropathies | Phase 2 | Status: NOT_YET_RECRUITING